Management of Soil-transmitted Helminthiasis and Strongyloidiasis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

2000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-12-31

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The general purpose of the project is to analyse soil-transmitted helminthiases (STH) in a highly endemic area in northern Argentina with a multidisciplinary approach. The specific objectives are to evaluate the local epidemiology of STH, validate a new diagnostic serology method for S. stercoralis and evaluate the efficacy and safety of a mass drug administration regimen with albendazole and ivermectin.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Urine Albendazole Levels for Coverage Assessment

NCT04041427

Helminthiasis

COMPLETED NA

Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study

NCT04999774

Strongyloidiasis Strongyloides Stercoralis Infection

COMPLETED

University-Based Chagas Testing in Salta Province, Argentina

NCT07033325

Chagas Disease Trypanosoma Cruzi Infection Chronic Chagas Disease

ENROLLING_BY_INVITATION

Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali

NCT02784743

Lymphatic Filariasis

COMPLETED PHASE4

Strongyloides Stercoralis Public Health Control in Rwanda

NCT07009613

Strongyloides Stercoralis Infection Strongyloides

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Helminthiasis Strongyloides Stercoralis Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ivermectin + Albendazole

Ivermectin: 200µg/kg, single dose, PO + Albendazole 200 (children between 12 and 23 months) or 400 mg (\>= 2 years old) single dose, PO

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All persons that are living in the working area at the time of the intervention and wish to participate in the study.

Exclusion Criteria

1. All persons that live within the study area but do not want to participate in the study.
2. Pregnant women or women who are likely pregnant.
3. Women during the first post-partum week if they are breastfeeding.
4. Children who weigh less than 15 kg.
5. Persons with a history of hypersensitivity or intolerance to ivermectin, albendazole or to the components that make up those drugs.

Minimum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes